- Ring-substituted histaprodifen analogues as partial agonists for histamine H1 receptors: Synthesis and structure-activity relationships
-
Thirteen racemic benzene ring-substituted analogues of histaprodifen (8a; 2-[2-(3,3-diphenylpropyl)-1H-imidazol-4-yl]ethanamine), a novel lead for potent and selective histamine H1-receptor agonists, have been prepared from substituted 4,4-diphenylbutyronitriles 5 via cyclization of the corresponding methyl butyrimidates 6 with 2-oxo-4-phthalimido-1-butyl acetate in liquid ammonia, followed by deprotection. Nitriles 5 were accessible by alkylation of either substituted diphenylmethanes with 3-bromopropionitrile or diethyl malonate with substituted 1-chloro-diphenylmethanes and subsequent standard reactions. The title compounds 8 displayed partial agonism on conctractile H1 receptors of the guinea-pig ileum (E(max) = 2-98% relative to histamine) and, compared with the endogenous agonist, were endowed with agonist potencies of 4-92%. The meta fluorinated (8c) and meta chlorinated (8f) analogues showed the highest relative potency in this series (95% confidence limits 85-99% and 78-102%), but did not exceed the value of the lead 8a (99- 124%). Compound 8c (2-[2-[3-(3-fluorophenyl)-3-phenylpropyl]-1H-imidazol-4- yl]ethanamine) was a partial agonist at contractile H1 receptors of the guinea-pig aorta (relative potency 154% vs. 100% for histamine) and at relaxation-mediating endothelial H1 receptors of the rat aorta (relative potency 556% vs. 100% for histamine) and matched with the functional behaviour of 8a. Agonism observed for each compound was sensitive to blockade by the selective H1-receptor antagonist mepyramine (pA2 ? 9 (guinea-pig) and pA2 ? 8 (rat aorta)). All histaprodifen analogues 8 stimulated neither histaminergic H2/H3 nor cholinergic M3 receptors. They displayed only low to moderate affinity for these sites (H2: pD'2 3/M3: pA2 1-receptor agonist, viz. 2- phenylhistamine. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
- Elz, Sigurd,Kramer, Kai,Leschke, Christian,Schunack, Walter
-
-
- N-(4-piperodinyl)(dihydrobenzofuran or dihydro-2H-benzopyran) carboxamide derivatives
-
Piperidine derivatives of formula STR1 wherein A is a radical of formula STR2 wherein one or two hydrogen atoms in said radicals (a-1) to (a-3) may be replaced by a C1-6 alkyl radical; R1 is hydrogen or halo; R2 is hydrogen, amino, mono or di(C1-6 alkyl)amino or C1-6 alkylcarbonylamino; R3 is hydrogen or C1-6 alkyl; L is C3-6 cycloalkyl, C5-6 cycloalkanone, C3-6 alkenyl optionally substituted with aryl, or L is a radical of formula STR3 the N-oxide forms, addition salts and stereochemically isomeric forms thereof, said compounds having gastrointestinal motility stimulating properties. Pharmaceutical compositions containing these compounds as active ingredient, and a method of preparing said compounds and pharmaceutical compositions.
- -
-
-
- Isochromane derivatives
-
An isochromane derivative having the general formula I STR1 in which each of R1, R2, and R3 is one to four substituents independently selected from hydrogen, hydroxy, alkyl (1-4 C), alkoxy (1-4 C), halogen, or CF3, or represents a methylenedioxy group; R4 is selected from hydrogen or alkyl (1-4 C); Alk is an alkylene group with 1-4 carbon atoms; Alk' is an alkylene group with 2-4 carbon atoms, when R5 is selected from hydrogen or alkyl (1-4 C) and X is O or S; or Alk' is an alkylene group with 1-4 carbon atoms or a bond, when R5 is an alkyl (1-4 C) group and X is CH2 or a bond; or a pharmaceutically acceptable salt thereof.
- -
-
-